Wednesday, June 17, 2026
HomeIndustriesBiotechnology

Biotechnology

REGENXBIO Presents Positive Interim Data from Phase II ALTITUDE Trial of RGX-314

REGENXBIO Inc. announced additional positive interim data from the ongoing Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy (DR) without...

U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major...

Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries

Ascletis Pharma Inc. announces that it has submitted marketing authorization applications for ritonavir (100 mg film-coated tablet) in Germany, France, Ireland and United Kingdom...

Pluslife Biotech -Launches First Handheld Covid-19 Nucleic Acid Test

Recently, Pluslife Biotech, an enterprise based in the Greater Bay Area, launched the first handheld Covid-19 Nucleic Acid Test to help with epidemic prevention...

Arkuda Raises $64 Million Series B Financing to Advance Pipeline of Programs

Arkuda Therapeutics, a biotechnology company applying novel insights at the intersection of lysosomal and microglial biology to develop medicines to change the trajectory of...

Hot Topics